The effect of zafirlukast (Accolate) on early capsular contracture in the primary augmentation patient: A pilot study | Zendy

Robert L. Reid | Zendy; S GREVE | Zendy; Lídia Casas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The effect of zafirlukast (Accolate) on early capsular contracture in the primary augmentation patient: A pilot study

Author(s) -

Robert L. Reid,

S GREVE,

Lídia Casas

Publication year - 2005

Publication title -

aesthetic surgery journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.528

H-Index - 58

eISSN - 1527-330X

pISSN - 1090-820X

DOI - 10.1016/j.asj.2004.12.003

Subject(s) - medicine , capsular contracture , zafirlukast , breast augmentation , augmentation mammoplasty , contracture , surgery , implant , leukotriene , breast reconstruction , asthma , breast cancer , cancer

The development of capsular contracture following breast augmentation presents a challenge to the plastic surgeon. Treatment of capsular contracture with the leukotriene antagonist zafirlukast (Accolate, AstraZeneca, Wayne, PA) has received much attention in the media; however, there is limited proof of its effectiveness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research